Erratum to: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
about
Erratum to: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@en
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@nl
type
label
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@en
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@nl
prefLabel
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@en
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@nl
P921
P1433
P1476
Erratum to: Proprotein convert ...... and atherogenic dyslipidemia.
@en
P2093
Massimiliano Ruscica
Nicola Ferri
P2888
P356
10.1007/S12020-016-1109-0
P577
2016-12-01T00:00:00Z